Advertisement

Pharmacokinetics of Creatine

  • Wesley Mccall
  • Adam M. Persky
Part of the Subcellular Biochemistry book series (SCBI, volume 46)

Abstract

Research has demonstrated that creatine supplementation has some therapeutic benefit with respect to muscle function and more recently neurological function. Despite the growing body of literature on the pharmacologic effect of creatine, very little is known about the disposition of creatine after supraphysiologic doses. The movement of creatine throughout the body is governed by transport processes which impact the absorption of creatine from the intestine, clearance of creatine from the kidney, and access of creatine to target tissues. With repeated doses of creatine, it appears that the clearance of creatine decreases mainly due to the saturation of skeletal muscle stores. Insulin and insulin-stimulating foods appear to enhance muscle uptake of creatine but at the same time, high carbohydrate meals may slow the absorption of creatine from the intestine. Little is known about creatine disposition in special populations including the elderly and patients with neuromuscular disease. Knowledge of creatine disposition in these clinically relevant populations can help remove some of the guess work of dose selection during clinical trials

Keywords

Renal Clearance Creatine Supplementation Solid Dosage Form Creatine Monohydrate Supraphysiologic Dose 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bender, A., Auer, D.P., Merl, T., Reilmann, R., Saemann, P., Yassouridis, A., Bender, J., Weindl, A., Dose, M., Gasser, T., and Klopstock, T., 2005, Creatine supplementation lowers brain glutamate levels in Huntington’s disease. J. Neurol. 252: 36–41.PubMedCrossRefGoogle Scholar
  2. Brose, A., Parise, G., and Tarnopolsky, M.A., 2003, Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. J. Gerontol. A Biol. Sci. Med. Sci. 58: 11–19.PubMedGoogle Scholar
  3. Cannan, R.K., and Shore, A., 1928, The creatine-creatinine equilibrium. The apparent dissociation constants of creatine and creatinine. Biochem. J. 22: 920–929.PubMedGoogle Scholar
  4. Christie, D.L., 2007, Functional insights into the creatine transporter. Subcell. Biochem. 46: 99–118.CrossRefPubMedGoogle Scholar
  5. Dash, A.K., Miller, D.W., Huai-Yan, H., Carnazzo, J., and Stout, J.R., 2001, Evaluation of creatine transport using Caco-2 monolayers as an in vitro model for intestinal absorption. J. Pharm. Sci. 90: 1593–1598.PubMedCrossRefGoogle Scholar
  6. Fitch, C.D., Lucy, D.D., Bornhofen, J.H., and Dalrymple, G.V., 1968, Creatine metabolism in skeletal muscle. II. Creatine kinetics in man. Neurology 18: 32–42.PubMedGoogle Scholar
  7. Green, A.L., Hultman, E., Macdonald, I.A., Sewell, D.A., and Greenhaff, P.L., 1996a, Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans. Am. J. Physiol. 271: E821–E826.Google Scholar
  8. Green, A.L., Simpson, E.J., Littlewood, J.J., Macdonald, I.A., and Greenhaff, P.L., 1996b, Carbohydrate ingestion augments creatine retention during creatine feeding in humans. Acta Physiol. Scand. 158: 195–202.CrossRefGoogle Scholar
  9. Harris, R.C., Nevill, M., Harris, D.B., Fallowfield, J.L., Bogdanis, G.C., and Wise, J.A., 2002, Absorption of creatine supplied as a drink, in meat or in solid form. J. Sports Sci. 20: 147–151.PubMedCrossRefGoogle Scholar
  10. Harris, R.C., Soderlund, K., and Hultman, E., 1992, Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin. Sci. (London) 83: 367–374.Google Scholar
  11. Hersch, S.M., Gevorkian, S., Marder, K., Moskowitz, C., Feigin, A., Cox, M., Como, P., Zimmerman, C., Lin, M., Zhang, L., Ulug, A.M., Beal, M.F., Matson, W., Bogdanov, M., Ebbel, E., Zaleta, A., Kaneko, Y., Jenkins, B., Hevelone, N., Zhang, H., Yu, H., Schoenfeld, D., Ferrante, R., and Rosas, H.D., 2006, Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2’dG. Neurology 66: 250–252.PubMedCrossRefGoogle Scholar
  12. Kreider, R.B., 2003, Species-specific responses to creatine supplementation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285: R725–R726.PubMedGoogle Scholar
  13. Lyoo, I.K., Kong, S.W., Sung, S.M., Hirashima, F., Parow, A., Hennen, J., Cohen, B.M., and Renshaw, P.F., 2003, Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate. Psychiatry Res. 123: 87–100.PubMedCrossRefGoogle Scholar
  14. Menshikova, E.V., Ritov, V.B., Fairfull, L., Ferrell, R.E., Kelley, D.E., and Goodpaster, B.H., 2006, Effects of exercise on mitochondrial content and function in aging human skeletal muscle. J. Gerontol. A Biol. Sci. Med. Sci. 61: 534–540.PubMedGoogle Scholar
  15. Meyer, R.A., Sweeney, H.L., and Kushmerick, M.J., 1984, A simple analysis of the ‘‘phosphocreatine shuttle’’. Am. J. Physiol. 246: C365–377.PubMedGoogle Scholar
  16. Neubauer, S., Remkes, H., Spindler, M., Horn, M., Wiesmann, F., Prestle, J., Walzel, B., Ertl, G., Hasenfuss, G., and Wallimann, T., 1999, Downregulation of the Na+-creatine cotransporter in failing human myocardium and in experimental heart failure. Circulation 100: 1847–1850.PubMedGoogle Scholar
  17. Orsenigo, M.N., Faelli, A., De Biasi, S., Sironi, C., Laforenza, U., Paulmichl, M., and Tosco, M., 2005, Jejunal creatine absorption: what is the role of the basolateral membrane? J. Membr. Biol. 207: 183–195.PubMedCrossRefGoogle Scholar
  18. Pang, K.S., and Rowland, M., 1977, Hepatic clearance of drugs. I. Theoretical considerations of a ‘‘well-stirred’’ model and a ‘‘parallel tube’’ model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J. Pharmacokinet. Biopharm. 5: 625–653.PubMedCrossRefGoogle Scholar
  19. Peral, M.J., Galvez, M., Soria, M.L., and Ilundain, A.A., 2005, Developmental decrease in rat small intestinal creatine uptake. Mech. Ageing Dev. 126: 523–530.PubMedCrossRefGoogle Scholar
  20. Peral, M.J., Gar cia-Delgado, M., Calonge, M.L., Duran, J.M., De La Horra, M.C., Wallimann, T., Speer, O., and Ilundain, A., 2002, Human, rat and chicken small intestinal Na+-Cl--creatine transporter: functional, molecular characterization and localization. J. Physiol. 545: 133–144.PubMedCrossRefGoogle Scholar
  21. Persky, A.M., Brazeau, G.A., and Hochhaus, G., 2003a, Pharmacokinetics of the dietary supplement creatine. Clin. Pharmacokinet. 42: 557–574.CrossRefGoogle Scholar
  22. Persky, A.M., Hochhaus, G., and Brazeau, G.A., 2003b, Validation of a simple liquid chromatography assay for creatine suitable for pharmacokinetic applications, determination of plasma protein binding and verification of percent labeled claim of various creatine products. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 794: 157–165.CrossRefGoogle Scholar
  23. Persky, A.M., Muller, M., Derendorf, H., Grant, M., Brazeau, G.A., and Hochhaus, G., 2003c, Single- and multiple-dose pharmacokinetics of oral creatine. J. Clin. Pharmacol. 43: 29–37.CrossRefGoogle Scholar
  24. Pitts, R., 1934, The clearance of creatine in dog and man. Am. J. Physiol. 109: 532–541.Google Scholar
  25. Poortmans, J.R., Auquier, H., Renaut, V., Durussel, A., Saugy, M., and Brisson, G.R., 1997, Effect of short-term creatine supplementation on renal responses in men. Eur. J. Appl. Physiol. Occup. Physiol. 76: 566–567.PubMedCrossRefGoogle Scholar
  26. Poortmans, J.R., and Francaux, M., 1999, Long-term oral creatine supplementation does not impair renal function in healthy athletes. Med. Sci. Sports Exerc. 31: 1108–1110.PubMedCrossRefGoogle Scholar
  27. Poortmans, J.R., Kumps, A., Duez, P., Fofonka, A., Carpentier, A., and Francaux, M., 2005, Effect of oral creatine supplementation on urinary methylamine, formaldehyde, and formate. Med. Sci. Sports Exerc. 37: 1717–1720.PubMedCrossRefGoogle Scholar
  28. Rawson, E.S., Clarkson, P.M., Price, T.B., and Miles, M.P., 2002, Differential response of muscle phosphocreatine to creatine supplementation in young and old subjects. Acta Physiol. Scand. 174: 57–65.PubMedCrossRefGoogle Scholar
  29. Schedel, J.M., Tanaka, H., Kiyonaga, A., Shindo, M., and Schutz, Y., 1999, Acute creatine ingestion in human: consequences on serum creatine and creatinine concentrations. Life Sci. 65: 2463–2470.PubMedCrossRefGoogle Scholar
  30. Snow, R.J., and Murphy, R.M., 2001, Creatine and the creatine transporter: a review. Mol. Cell. Biochem. 224: 169–181.PubMedCrossRefGoogle Scholar
  31. Speer, O., Neukomm, L.J., Murphy, R.M., Zanolla, E., Schlattner, U., Henry, H., Snow, R.J., and Wallimann, T., 2004, Creatine transporters: a reappraisal. Mol. Cell. Biochem. 256–257: 407–424.PubMedCrossRefGoogle Scholar
  32. Steenge, G.R., Lambourne, J., Casey, A., Macdonald, I.A., and Greenhaff, P.L., 1998, Stimulatory effect of insulin on creatine accumulation in human skeletal muscle. Am. J. Physiol. 275: E974–979.PubMedGoogle Scholar
  33. Steenge, G.R., Simpson, E.J., and Greenhaff, P.L., 2000, Protein- and carbohydrate-induced augmentation of whole body creatine retention in humans. J. Appl. Physiol. 89: 1165–1171.PubMedGoogle Scholar
  34. Tabrizi, S.J., Blamire, A.M., Manners, D.N., Rajagopalan, B., Styles, P., Schapira, A.H., and Warner, T.T., 2003, Creatine therapy for Huntington’s disease: clinical and MRS findings in a 1-year pilot study. Neurology 61: 141–142.PubMedGoogle Scholar
  35. Tappy, L., Randin, J.P., Felber, J.P., Chiolero, R., Simonson, D.C., Jequier, E., and DeFronzo, R.A., 1986, Comparison of thermogenic effect of fructose and glucose in normal humans. Am. J. Physiol. 250: E718–724.PubMedGoogle Scholar
  36. Tarnopolsky, M., Parise, G., Fu, M.H., Brose, A., Parshad, A., Speer, O., and Wallimann, T., 2003a, Acute and moderate-term creatine monohydrate supplementation does not affect creatine transporter mRNA or protein content in either young or elderly humans. Mol. Cell. Biochem. 244: 159–166.CrossRefGoogle Scholar
  37. Tarnopolsky, M.A., Bourgeois, J.M., Snow, R., Keys, S., Roy, B.D., Kwiecien, J.M., and Turnbull, J., 2003b, Histological assessment of intermediate- and long-term creatine monohydrate supplementation in mice and rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285: R762–769.Google Scholar
  38. Tarnopolsky, M.A., Parshad, A., Walzel, B., Schlattner, U., and Wallimann, T., 2001, Creatine transporter and mitochondrial creatine kinase protein content in myopathies. Muscle Nerve 24: 682–688.PubMedCrossRefGoogle Scholar
  39. Tosco, M., Faelli, A., Sironi, C., Gastaldi, G., and Orsenigo, M.N., 2004, A creatine transporter is operative at the brush border level of the rat jejunal enterocyte. J. Membr. Biol. 202: 85–95.PubMedCrossRefGoogle Scholar
  40. Truswell, A.S., 1992, Glycaemic index of foods. Eur. J. Clin. Nutr. 46 Suppl 2: S91–S101.PubMedGoogle Scholar
  41. Twort, F.W., and Mellanby, E., 1912, On creatin-destroying Bacilli in the intestine and their isolation. J. Physiol. 44: 43–49.PubMedGoogle Scholar
  42. Vandenberghe, K., Goris, M., Van Hecke, P., Van Leemputte, M., Vangerven, L., and Hespel, P., 1997, Long-term creatine intake is beneficial to muscle performance during resistance training. J. Appl. Physiol. 83: 2055–2063.PubMedGoogle Scholar
  43. Vist, G.E., and Maughan, R.J., 1995, The effect of osmolality and carbohydrate content on the rate of gastric emptying of liquids in man. J. Physiol. 486: 523–531.PubMedGoogle Scholar
  44. Walker, J.B., 1979, Creatine: biosynthesis, regulation, and function. Adv. Enzymol. Relat. Areas Mol. Biol. 50: 177–242.PubMedCrossRefGoogle Scholar
  45. Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., and Eppenberger, H.M., 1992, Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ’phosphocreatine circuit’ for cellular energy homeostasis. Biochem. J. 281: 21–40.PubMedGoogle Scholar
  46. Wilkinson, I.D., Mitchel, N., Breivik, S., Greenwood, P., Griffiths, P.D., Winter, E.M., and Van Beek, E.J., 2006, Effects of creatine supplementation on cerebral white matter in competitive sportsmen. Clin. J. Sport Med. 16: 63–67.PubMedCrossRefGoogle Scholar
  47. Wixom, R.L., Davis, G.E., Flynn, M.A., Tsutakawa, R.T., and Hentges, D.J., 1979, Excretion of creatine and creatinine in feces of man. Proc. Soc. Exp. Biol. Med. 161: 452–457.PubMedGoogle Scholar
  48. Wyss, M., and Schulze, A., 2002, Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease? Neuroscience 112: 243–260.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Wesley Mccall
    • 1
  • Adam M. Persky
    • 1
  1. 1.Division of pharmacotherapy and Experimental Therapeutics, School of PharmacyUniversity of North Carolina at Chapel HillChapel HillUSA

Personalised recommendations